Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hannah Collacott
Observed name:
H. Collacott
Institutions:
Pharmaceutical Product Development (United States),
Thermo Fisher Scientific (United States)
Observed institutions:
Pharmaceutical Product Development (United States),
University of Aberdeen,
Thermo Fisher Scientific (United States),
Idorsia Pharmaceuticals Ltd (Switzerland)
ORCID:
0000-0002-3915-8599
Observed ORCID:
0000-0002-3915-8599
OpenAlex ID:
A5056286911
A Systematic Review of Discrete Choice Experiments in Oncology Treatments
2021
·
Hannah Collacott
, Vikas Soekhai
, et al.
·
Patient
·
53
PDF
How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations
2021
·
Kevin Marsh
, Esther de Bekker-Grob
, et al.
·
International Journal of Technology Assessment in Health Care
·
23
Patient Preferences for Treatment of Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: A Cross-country Choice Experiment
2023
·
Hannah Collacott
, Nicolas Krucien
, et al.
·
European Urology Open Science
·
22
Patient and Physician Preferences for Regimen Attributes for the Treatment of HIV in the United States and Canada
2022
·
Heather Gelhorn
, Cindy Garris
, et al.
·
Journal of Personalized Medicine
·
20
PDF
A Systematic and Critical Review of Discrete Choice Experiments in Asthma and Chronic Obstructive Pulmonary Disease
2021
·
Hannah Collacott
, Dian Zhang
, et al.
·
Patient
·
20
PDF
Patient Perceptions Regarding Multiple Myeloma and Its Treatment: Qualitative Evidence from Interviews with Patients in the United Kingdom, France, and Germany
2021
·
Jianming He
, Ashley Duenas
, et al.
·
Patient
·
18
PDF
Current Health State Affected Patient Preferences More Than Disease Status: A Discrete Choice Experiment in Multiple Myeloma
2023
·
Tommi Tervonen
, Ashley Duenas
, et al.
·
Value in Health
·
12
PDF
Designing financial incentives for health behaviour change: a mixed-methods case study of weight loss in men with obesity
2022
·
Marjon van der Pol
, Matthew McDonald
, et al.
·
Journal of Public Health
·
8
PDF
Experienced or Perceived Burdens and Associated Quality of Life Impacts of Anemia and Transfusion Dependence in Myelofibrosis: A Patient Self-Report Survey Analysis
2024
·
Thomas W. LeBlanc
, Hannah Collacott
, et al.
·
Blood
·
5
PDF
Patient and clinician preferences for biologic treatments for severe uncontrolled asthma: a discrete choice experiment (DCE)
2024
·
Melissa M. Ross
, Yen Chung
, et al.
·
Journal of Asthma
·
5
2499. Perceptions of and Preferences for Oral or Long-Acting Injectable Antiretroviral Treatment Regimens in the United States and Canada
2019
·
Cindy Garris
, Sebastian Heidenreich
, et al.
·
Open Forum Infectious Diseases
·
4
Patients’ Preferences for Systemic Lupus Erythematosus Treatments—A Discrete Choice Experiment
2024
·
Hannah Collacott
, Andrea Phillips-Beyer
, et al.
·
Patient
·
2
Perceptions of menopausal symptoms and their treatment: qualitative evidence from interviews with menopausal women in the US, the UK and Germany
2023
·
Paula Briggs
, Katrin Schaudig
, et al.
·
Maturitas
·
2
Patient (pt) experience with and perceptions of transfusion-dependent (TD) and transfusion-independent (TI) myelofibrosis (MF): A qualitative interview study.
2024
·
Anna Cardellino
, Hannah Collacott
, et al.
·
Journal of Clinical Oncology
·
1
Using Patient Preferences in Health Technology Assessment: Evaluating Quality-Adjusted Survival Equivalents (QASE) for the Quantification of Non-health Benefits
2024
·
Kevin Marsh
, Hannah Collacott
, et al.
·
Patient
·
1
P54 Patient Preferences for Treatment of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: A Discrete Choice Experiment
2022
·
H. Collacott
, A. Rentz
, et al.
·
Value in Health
·
1
PDF
Correction to: A Systematic and Critical Review of Discrete Choice Experiments in Asthma and Chronic Obstructive Pulmonary Disease
2021
·
Hannah Collacott
, Dian Zhang
, et al.
·
Patient
·
1
PDF
PCN319 A Systematic Review of Discrete Choice Experiments in Oncology: Status-Quo and Implications
2020
·
H. Collacott
, V. Soekhai
, et al.
·
Value in Health
·
1
Pcn332 Patient Perceptions Regarding Multiple Myeloma and Its Treatment: Qualitative Evidence From Interviews With Newly Diagnosed and Relapsed-refractory Patients in the United Kingdom, France, and Germany
2020
·
J. He
, A. Duenas
, et al.
·
Value in Health
·
1
PDF
Perceived and experienced impacts of anemia and transfusion dependence in myelofibrosis: a mixed-methods study
2026
·
Anna Cardellino
, Hannah Collacott
, et al.
·
BMC Cancer
Patient and clinician preferences for adjuvant treatment following surgical resection in early-stage non-small cell lung cancer: A multi-country discrete choice experiment
2026
·
Christine Michaels-Igbokwe
, Hannah Collacott
, et al.
·
Lung Cancer
Patient and physician preferences for treatments of metastatic castrate resistant prostate cancer
2024
·
E. Castro
, R. Jones
, et al.
·
European Urology
P-310 Treatment preferences among triple-class exposed patients with relapsed/refractory multiple myeloma in the United States (US), United Kingdom (UK), and Germany (DE): a discrete choice experiment
2023
·
Paula Rodriguez-Otero
, Christine Michaels-Igbokwe
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P56 Patient Preferences in Multiple Myeloma: A Discrete Choice Experiment
2022
·
T. Tervonen
, A. Duenas
, et al.
·
Value in Health
PDF
Pos0086-pare Patient Preferences for Systemic Lupus Erythematosus Treatments: a Discrete Choice Experiment
2022
·
H. Collacott
, A. Phillips-Beyer
, et al.
·
Annals of the Rheumatic Diseases
PDF
Show more works
View as search
Works count:
28
Citation count:
200
H-index:
8
I10-index:
7
Year
Topic
Type